{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:45:32Z","timestamp":1772120732147,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS065783"],"award-info":[{"award-number":["R01NS065783"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS089396"],"award-info":[{"award-number":["R21NS089396"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sudha Neelakantan and Venky Harinarayan Charitable Fund"},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["237168"],"award-info":[{"award-number":["237168"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["264551"],"award-info":[{"award-number":["264551"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.expneurol.2016.12.008","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T18:05:58Z","timestamp":1482429958000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy"],"prefix":"10.1016","volume":"289","author":[{"given":"Jesus-Servando","family":"Medel-Matus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Mazarati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.12.008_bb0005","doi-asserted-by":"crossref","first-page":"e1532","DOI":"10.1542\/peds.2011-0245","article-title":"Psychiatric and medical comorbidity and quality of life outcomes in childhood-onset epilepsy","volume":"128","author":"Baca","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0010","series-title":"The Neurobiological Basis of Suicide","article-title":"Noradrenergic dysfunction in depression and suicide","author":"Chandley","year":"2012"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1471-4159.2002.01148.x","article-title":"Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons","volume":"83","author":"Counts","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0025","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/jnc.13528","article-title":"Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release","volume":"136","author":"Dankoski","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnint.2013.00044","article-title":"Monitoring serotonin signaling on a subsecond time scale","volume":"7","author":"Dankoski","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0031-9384(89)90261-8","article-title":"Learned immobility explains the behavior of rats in the forced swimming test","volume":"46","author":"De Pablo","year":"1989","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yebeh.2013.06.023","article-title":"Antidepressant and anticonvulsant effects of exercise in a rat model of epilepsy and depression comorbidity","volume":"29","author":"Epps","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/epi.12549","article-title":"Attention and executive functions in a rat model of chronic epilepsy","volume":"55","author":"Faure","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3940(90)90570-Y","article-title":"Localization of preprogalanin mRNA in rat brain: in situ hybridization study with a synthetic oligonucleotide probe","volume":"114","author":"Gundlach","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0055","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1152\/jn.00620.2011","article-title":"In vivo voltammetry monitoring of electrically evoked extracellular norepinephrine in subregions of the bed nucleus of the stria terminalis","volume":"107","author":"Herr","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.1998.tb10700.x","article-title":"Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline","volume":"863","author":"H\u00f6kfelt","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbr.2004.07.011","article-title":"Impaired visuospatial divided attention in the spontaneously hypertensive rat","volume":"157","author":"Jentsch","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00213-008-1181-0","article-title":"Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats","volume":"202","author":"Jentsch","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0075","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-3223(03)00469-4","article-title":"Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment","volume":"54","author":"Kanner","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","article-title":"Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence","volume":"24","author":"Kanner","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0090","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/epi.13321","article-title":"Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy","volume":"57","author":"Kumar","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0095","first-page":"163","article-title":"Galanin, galanin receptor subtypes and depression-like behaviour","volume":"102","author":"Kuteeva","year":"2010","journal-title":"EXS"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0100","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/sj.npp.1301660","article-title":"Differential role of galanin receptors in the regulation of depression-like behavior and monoamine\/stress-related genes at the cell body level","volume":"33","author":"Kuteeva","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/pr.112.006536","article-title":"Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity","volume":"67","author":"Lang","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0110","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1073\/pnas.1221378110","article-title":"Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe","volume":"110","author":"Le Maitre","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0115","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1073\/pnas.0408891102","article-title":"A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/NMM:7:1-2:157","article-title":"Galanin and its receptors in neurological disorders","volume":"7","author":"Lundstrom","year":"2005","journal-title":"Neruomol. Med."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0125","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","article-title":"Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments","volume":"52","author":"Luoni","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.npep.2004.12.003","article-title":"Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors","volume":"39","author":"Mazarati","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0135","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1124\/jpet.106.104703","article-title":"Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: the effects of subtype-selective agonists and the role of G-protein-mediated signaling","volume":"318","author":"Mazarati","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0140","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/brain\/awn117","article-title":"Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine","volume":"131","author":"Mazarati","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0145","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.2005.03498.x","article-title":"In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures","volume":"95","author":"Mazarati","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0150","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1523\/JNEUROSCI.20-16-06276.2000","article-title":"Modulation of hippocampal excitability and seizures by galanin","volume":"20","author":"Mazarati","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0155","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1523\/JNEUROSCI.18-23-10070.1998","article-title":"Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus","volume":"18","author":"Mazarati","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.11.001","article-title":"Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta","volume":"37","author":"Mazarati","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0165","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1523\/JNEUROSCI.06-12-03640.1986","article-title":"Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS","volume":"6","author":"Melander","year":"1986","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0170","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0301-0082(93)90012-H","article-title":"Anatomy and physiology of central galanin-containing pathways","volume":"40","author":"Merchenthaler","year":"1993","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneumeth.2010.12.015","article-title":"Repeated rat-forced swim test: reducing the number of animals to evaluate gradual effects of antidepressants","volume":"195","author":"Mezadri","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0180","first-page":"7","article-title":"Galanin, galanin receptors, and drug targets","volume":"102","author":"Mitsukawa","year":"2010","journal-title":"EXS"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.braindev.2009.03.005","article-title":"Attention deficit hyperactivity disorder in children with epilepsy","volume":"32","author":"Parisi","year":"2010","journal-title":"Brain and Development"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0190","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1460-9568.2009.07005.x","article-title":"In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus","volume":"30","author":"Park","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0195","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1471-4159.2011.07494.x","article-title":"In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry","volume":"119","author":"Park","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0200","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxions","year":"1986"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2009.08.033","article-title":"Effects of galanin on monoaminergic systems and HPA axis: potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors","volume":"1314","author":"Picciotto","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0210","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0306-4522(94)00450-J","article-title":"Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice","volume":"64","author":"Pieribone","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yebeh.2013.10.004","article-title":"Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit\/hyperactivity disorder","volume":"31","author":"Pineda","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0220","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/npp.2011.18","article-title":"Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression","volume":"36","author":"Pineda","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13311-012-0110-4","article-title":"Interleukin-1beta causes fluoxetine resistance in an animal model of epilepsy-associated depression","volume":"9","author":"Pineda","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.expneurol.2006.02.124","article-title":"Galanin expressed in the excitatory fibers attenuates synaptic strength and generalized seizures in the piriform cortex of mice","volume":"200","author":"Schlifke","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2004.06.007","article-title":"Attention deficit disorder and epilepsy","volume":"32","author":"Schubert","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0240","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0196-9781(86)90035-5","article-title":"Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system","volume":"7","author":"Skofitsch","year":"1986","journal-title":"Peptides"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0245","doi-asserted-by":"crossref","first-page":"23321","DOI":"10.1074\/jbc.273.36.23321","article-title":"Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels","volume":"273","author":"Smith","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0250","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1021\/bi9728405","article-title":"Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes","volume":"37","author":"Wang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2016.12.008_bb0255","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fendo.2012.00146","article-title":"Galanin receptors and ligands","volume":"3","author":"Webling","year":"2012","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0260","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/cn4000378","article-title":"Fast-scan cyclic voltammetry analysis of dynamic serotonin reponses to acute escitalopram","volume":"4","author":"Wood","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2016.12.008_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0306-4522(98)00151-1","article-title":"Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors","volume":"87","author":"Xu","year":"1998","journal-title":"Neuroscience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616304174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616304174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T17:25:46Z","timestamp":1568654746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616304174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":53,"alternative-id":["S0014488616304174"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.12.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727144383.793527891","asserted-by":"object"}]},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}